Detalhe da pesquisa
1.
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021).
Lancet Oncol
; 23(7): 899-909, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35690072
2.
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.
Future Oncol
; 18(10): 1185-1198, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034502
3.
Patient-reported outcomes of multiple myeloma patients treated with panobinostat after ≥2 lines of therapy based on the international phase 3, randomized, double-blind, placebo-controlled PANORAMA-1 trial.
Br J Haematol
; 181(5): 628-636, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29774521
4.
REACT expanded-access program in patients with metastatic renal cell carcinoma: real-world data from a European subanalysis.
Future Oncol
; 11(21): 2893-903, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26376939
5.
Everolimus plus octreotide long-acting repeatable in patients with colorectal neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-2 study.
Oncologist
; 18(1): 46-53, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23263288
6.
Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study.
J Clin Oncol
; 39(33): 3725-3736, 2021 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34491815
7.
Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant.
Am J Hematol
; 84(8): 484-7, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19536846
8.
Outcomes of patients with stable heart failure undergoing elective noncardiac surgery.
Mayo Clin Proc
; 83(3): 280-8, 2008 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-18315993
9.
Apoptosis mechanisms related to the increased sensitivity of Jurkat T-cells vs A431 epidermoid cells to photodynamic therapy with the phthalocyanine Pc 4.
Photochem Photobiol
; 84(2): 407-14, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18221452
10.
Dexmedetomidine sedation for laryngeal framework surgery.
Ann Otol Rhinol Laryngol
; 117(9): 659-64, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18834067
11.
Treatment-free interval as a metric of patient experience and a health outcome of value for advanced multiple myeloma: the case for the histone deacetylase inhibitor panobinostat, a next-generation novel agent.
Expert Rev Hematol
; 10(10): 933-939, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28885063
12.
Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial.
Pancreas
; 44(2): 181-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25479584
13.
Efficacy of everolimus with exemestane versus exemestane alone in Asian patients with HER2-negative, hormone-receptor-positive breast cancer in BOLERO-2.
Breast Cancer
; 21(6): 703-14, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23404211
14.
Everolimus plus octreotide long-acting repeatable in patients with advanced lung neuroendocrine tumors: analysis of the phase 3, randomized, placebo-controlled RADIANT-2 study.
Chest
; 143(4): 955-962, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23187897
15.
Safety of everolimus by treatment duration in patients with advanced renal cell cancer in an expanded access program.
Urology
; 81(1): 143-9, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23273080
16.
Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study.
Eur J Cancer
; 49(12): 2621-32, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23735704
17.
Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.
Clin Breast Cancer
; 13(6): 421-432.e8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24267730
18.
Topical application of activity-based probes for visualization of brain tumor tissue.
PLoS One
; 7(3): e33060, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22427947
19.
Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: analysis of response and progression-free survival in the RECORD-1 study.
Eur J Cancer
; 48(10): 1512-8, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22342553
20.
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial.
Eur Urol
; 61(4): 826-33, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22297244